The Food and Drug Administration (FDA) has endorsed 10 additional drug products for inclusion in the Bureau of Internal Revenue’s (BIR) list of Value-Added Tax (VAT)-exempt medicines. In FDA Advisory No. 2025-0510 issued on June 4, the agency identified the newly endorsed products, which include...